Life Sciences Companies Investors Presentations Now Available for On-Demand Viewing
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
NEW YORK, March 30, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced that the presentations from its inaugural conference are now available for on-demand viewing at LifeSciencesInvestorForum.com.
This virtual event showcased live company presentations and interactive discussions focused on the life sciences industry. The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download shareholder materials from the company’s “virtual trade booth”.
REGISTER OR LOGIN AT: https://tinyurl.com/LSIF032620-PostAgendaPR
March 26th Presenting Companies:
| Company | Ticker |
| RedHill Biopharma Ltd. | Nasdaq: RDHL |
| Nuvo Pharmaceuticals Inc. | OTCQX: NRIFF | TSX: NRI |
| Orexo AB | OTCQX: ORXOY | Nasdaq STO: ORX |
| Emmaus Life Sciences, Inc. | OTCQB: EMMA |
| Moleculin Biotech, Inc. | Nasdaq: MBRX |
| Lexaria Bioscience Corp. | OTCQX: LXRP | CSE: LXX |
| Beroni Group Ltd. | OTCQX: BNIGF | NSX: BTG |
To facilitate investor relations scheduling and for more information about the program, please visit www.lifesciencesinvestorforum.com.
About Life Sciences Investor Forum
Life Sciences Investor Forum is the leading proprietary investor conference series that provides an interactive forum for Life Sciences companies to meet with and present directly to investors.
A real-time solution for investor engagement, Life Sciences Investor Forum is powered by Intrado Digital Media and specifically designed for more efficient investor access. Replicating the look and feel of on-site investor conferences, Life Sciences Investor Forum combines leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.
CONTACT Life Sciences Investor Forum John M. Viglotti SVP Corporate Services, Investor Access (212) 220-2221 [email protected]
